U.S. Food and Drug Administration

While the governor said the treatments are "not 100%," he added that they should still be made available.

You probably won't be testing everyone at your Thanksgiving table for COVID because the tests are expensive and hard to find. The federal government is partly to blame.

A Tampa pediatrician will make a presentation to the Food and Drug Administration’s advisory committee when it meets on Tuesday to recommend whether to approve a COVID-19 vaccine for young children.

The state, which continues to wait for FDA approval, expects to import drugs to treat asthma, COPD, diabetes, hepatitis C, HIV and AIDS, and mental health conditions.

The condition can be an early signal of Alzheimer’s but not always. Other health concerns could be causing thinking or memory problems, and the new drug, Aduhelm, would not be appropriate for those patients.

Federal, state and municipal governments as well as private businesses continue to largely avoid mandates out of fears they will provoke a backlash. So, how about an economic argument?

Pfizer said in late March that clinical trials found "100% efficacy and robust antibody responses" to the coronavirus in 12- to 15-year-olds.

The third COVID-19 vaccine authorized for use in the U.S. requires one shot instead of two, and works a slightly different way from the others. Here's what we know about its safety and effectiveness.

The new deal effectively doubles the federal government's order from the company. Pfizer said the U.S. government has agreed to pay $1.95 billion for the additional doses.

The Food and Drug Administration greenlights the biotech firm's vaccine for emergency use in the U.S. The move bolsters a vast inoculation effort that's already underway.

Advisers to the Food and Drug Administration voted 20-0 to recommend that the agency authorize Moderna's vaccine for emergency use during the pandemic. There was a single abstention.

Two days before a panel of experts is set to review Moderna's COVID-19 vaccine and advise the Food and Drug Administration, documents show the vaccine is 94% effective and well-tolerated.